Aspirin Versus Clopidogrel Monotherapy for the Treatment of Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis

INTRODUCTION: Although aspirin (ASA) is the mainstay of treatment for the prevention of recurrent ischemic stroke, the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) trial showed ASA monotherapy to be inferior to clopidogrel in preventing recurrent adverse cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jun, Xu, Guang Ma, Ding, Jiawang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822863/
https://www.ncbi.nlm.nih.gov/pubmed/31154631
http://dx.doi.org/10.1007/s12325-019-01004-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822863/
https://www.ncbi.nlm.nih.gov/pubmed/31154631
http://dx.doi.org/10.1007/s12325-019-01004-6

Ejemplares similares